PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.
Known title: 10% OwnerCIK: 0001166152
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.'s purchase track record
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. has no open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/6/2026 | NATR | $2.32M | pending | pending | — |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| NATR | ▲ Buy | Open Market | 16,928 | $267K | 8/10/2026 | View on chart |
| NATR | ▲ Buy | Open Market | 13,072 | $206K | 8/10/2026 | View on chart |
| NATR | ▲ Buy | Open Market | 10,000 | $160K | 8/10/2026 | View on chart |
| NATR | ▲ Buy | Open Market | 876 | $14K | 8/10/2026 | View on chart |
| NATR | ▲ Buy | Open Market | 10,000 | $165K | 8/7/2026 | View on chart |
| NATR | ▲ Buy | Open Market | 1,000 | $16K | 8/7/2026 | View on chart |
| NATR | ▲ Buy | Open Market | 20,000 | $331K | 8/7/2026 | View on chart |
| NATR | ▲ Buy | Open Market | 5,000 | $83K | 8/7/2026 | View on chart |
| NATR | ▲ Buy | Open Market | 30,000 | $500K | 8/7/2026 | View on chart |
| NATR | ▲ Buy | Open Market | 20,000 | $334K | 8/7/2026 | View on chart |
| NATR | ▲ Buy | Open Market | 10,000 | $167K | 8/7/2026 | View on chart |
| NATR | ▲ Buy | Open Market | 2,000 | $33K | 8/6/2026 | View on chart |
| NATR | ▲ Buy | Open Market | 2,513 | $42K | 8/6/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Nature's Sunshine Q2 Earnings Reviewed Against Peers
A recent analysis compared Nature's Sunshine's second-quarter results with other personal care companies. This review helps investors understand how the stock performed relative to its sector during that period. The company currently trades with a trailing P/E ratio of 13.3, while analysts maintain an average price target of $30.50.
Nature's Sunshine Q2 Earnings Reviewed Against Peers. A recent analysis compared Nature's Sunshine's second-quarter results with other personal care companies. This review helps investors understand how the stock performed relative to its sector during that period. The company currently trades with a trailing P/E ratio of 13.3, while analysts maintain an average price target of $30.50.